Ann Hynes
Stock Analyst at Mizuho
(4.39)
# 352
Out of 4,966 analysts
253
Total ratings
64.89%
Success rate
11.98%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $32 → $22 | $22.96 | -4.18% | 12 | Aug 14, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $350 → $300 | $309.87 | -3.19% | 20 | Aug 7, 2025 | |
| MEDP Medpace Holdings | Maintains: Outperform | $328 → $510 | $475.51 | +7.25% | 3 | Jul 25, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $190 → $225 | $190.81 | +17.92% | 13 | Jul 25, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $173 → $225 | $177.94 | +26.45% | 16 | Jul 25, 2025 | |
| THC Tenet Healthcare | Maintains: Outperform | $184 → $194 | $184.33 | +5.25% | 15 | Jul 11, 2025 | |
| MOH Molina Healthcare | Maintains: Outperform | $400 → $330 | $180.83 | +82.49% | 9 | Jul 11, 2025 | |
| FTRE Fortrea Holdings | Maintains: Neutral | $8 → $7 | $9.85 | -28.93% | 4 | Jul 11, 2025 | |
| CNC Centene | Maintains: Neutral | $71 → $40 | $29.04 | +37.74% | 8 | Jul 11, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $178 → $189 | $181.64 | +4.05% | 15 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $305 → $316 | $303.66 | +4.06% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $455 → $505 | $318.65 | +58.48% | 4 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $155 | $163.31 | -5.09% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $76 | $73.15 | +3.90% | 10 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $18 | $12.69 | +41.84% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $17.21 | -12.84% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $148.78 | -19.34% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $23.69 | -15.58% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $23.80 | +17.65% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $121.76 | -21.98% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $300.87 | +27.96% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $181.58 | +10.14% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $2.65 | +10,013.21% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $686.64 | -26.45% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $277.99 | -17.26% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $403.96 | -31.92% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $22.69 | +120.36% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.61 | +3,449.19% | 1 | Sep 21, 2017 |
Acadia Healthcare Company
Aug 14, 2025
Maintains: Neutral
Price Target: $32 → $22
Current: $22.96
Upside: -4.18%
UnitedHealth Group
Aug 7, 2025
Maintains: Outperform
Price Target: $350 → $300
Current: $309.87
Upside: -3.19%
Medpace Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $328 → $510
Current: $475.51
Upside: +7.25%
IQVIA Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $190.81
Upside: +17.92%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $177.94
Upside: +26.45%
Tenet Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $184 → $194
Current: $184.33
Upside: +5.25%
Molina Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $400 → $330
Current: $180.83
Upside: +82.49%
Fortrea Holdings
Jul 11, 2025
Maintains: Neutral
Price Target: $8 → $7
Current: $9.85
Upside: -28.93%
Centene
Jul 11, 2025
Maintains: Neutral
Price Target: $71 → $40
Current: $29.04
Upside: +37.74%
Quest Diagnostics
Apr 9, 2025
Maintains: Outperform
Price Target: $178 → $189
Current: $181.64
Upside: +4.05%
Apr 9, 2025
Maintains: Outperform
Price Target: $305 → $316
Current: $303.66
Upside: +4.06%
Apr 9, 2025
Maintains: Outperform
Price Target: $455 → $505
Current: $318.65
Upside: +58.48%
Apr 9, 2025
Maintains: Neutral
Price Target: $175 → $155
Current: $163.31
Upside: -5.09%
Apr 9, 2025
Maintains: Outperform
Price Target: $70 → $76
Current: $73.15
Upside: +3.90%
Apr 9, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $12.69
Upside: +41.84%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $17.21
Upside: -12.84%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $148.78
Upside: -19.34%
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $23.69
Upside: -15.58%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $23.80
Upside: +17.65%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $121.76
Upside: -21.98%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $300.87
Upside: +27.96%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $181.58
Upside: +10.14%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $2.65
Upside: +10,013.21%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $686.64
Upside: -26.45%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $277.99
Upside: -17.26%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $403.96
Upside: -31.92%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $22.69
Upside: +120.36%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.61
Upside: +3,449.19%